1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE SERVICES
  4. VIJAYA DIAGNOSTIC CENTRE LTD.
Vijaya Diagnostic Centre Ltd.
NSE: VIJAYA | BSE: 543350

Vijaya Diagnostic Centre Live Share Price Today, Share Analysis and Chart

Expensive Performer
aboutVijaya Diagnostic Centre Limited, established in 1981, is a leading integrated diagnostic service provider in India, with a dominant presence in Southern India, particularly Telangana and Andhra Pradesh. The company operates a comprehensive business ... Read More
Revenue per PatientTests Performed
Ask AI about Vijaya Diagnostic Centre
1445.70-18.50(-1.26%)
54,235
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Vijaya Diagnostic Centre is on 03 Nov 2026 for the purpose of Quarterly Results See details
Loading...
- / 100
- / 100
58.4 / 100
Expensive PerformerThese stocks are strong in quality but with mid-range technicals. Their valuations are expensiveView SimilarEmbed DVM
Analyst Price Target
-

21

S

9

W

4

O

0

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

13Positive10Negative

Pass in checklist56.5%

045
55
100

PE Valuation Check

Right Now
Overvalued
-17.5%
1 Year Forward
Fairly Valued
-1.4%
INSIGHTVijaya Diagnostic Centre is overvalued at current PE, but fairly valued on future earnings estimates

Vijaya Diagnostic Centre Stock Price Analysis

Day Price Range

-1.3% 1 Day return
1445.7 (LTP)
1,435.11,478.9
LowHigh

Week Price Range

4.0% 1 Week return
1445.7 (LTP)
1,3691,478.9
LowHigh

Month Price Range

0.6% 1 Month return
1445.7 (LTP)
1,3351,501
LowHigh

52 Week Price Range

46.2% 1 Year return
1445.7 (LTP)
8481,593.6
LowHigh
View full Price History/Seasonality

Vijaya Diagnostic Centre Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Hit

Vijaya Diagnostic Centre's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

CURRENT EPS
16.8
AVG. ESTIMATE
21.8
LOW ESTIMATE
21
HIGH ESTIMATE
23.3
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 29.5% in FY27

Consensus Recommendation

9 ANALYST Recommendations
STRONG BUY

The consensus recommendation from 9 analysts for Vijaya Diagnostic Centre is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Vijaya Diagnostic Centre Technical Analysis

Vijaya Diagnostic Centre EMA & SMA

Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
5 Day1437.8
10 Day1426.0
12 Day1425.1
20 Day1429.3
26 Day1433.6
50 Day1435.0
100 Day1389.2
200 Day1289.5

Vijaya Diagnostic Centre Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202646.4%
Week61.9%
Month58.5%

Vijaya Diagnostic Centre Active Candlesticks

Long Legged Doji Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Vijaya Diagnostic Centre Resistance and Support

1453.23
Pivot
First Resistance1471.4
Second Resistance1497.0
Third Resistance1515.2
First Support1427.6
Second Support1409.4
Third Support1383.8
Day RSI52.3
Day MACD-8.5
Day MFI40.3
Day MACD Signal Line-16.9

Vijaya Diagnostic Centre Beta

1 Month0.1
1 Year0.5
3 Month0.5
3 Year0.4

Vijaya Diagnostic Centre Price Change Analysis

↑0.6%
Over 1 Month
LowHigh
13351501
↑7.5%
Over 3 Months
LowHigh
1334.61593.6
↑28.0%
Over 6 Months
LowHigh
11361593.6
↑46.2%
Over 1 Year
LowHigh
8481593.6
All Technicals →

Vijaya Diagnostic Centre Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Surendranath Reddy SuraPromoter33,166,30932.2 %
Verdipapirfondet Odin Emerging MarketsFii1,050,0001.0 %
Kotak Mahindra Trustee Co Ltd A/C Kotak Business CDii6,784,4846.6 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Vijaya Diagnostic Centre Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPBulkSell08 Apr 2025983.691,170,344NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase08 Apr 2025983.511,170,344NSE
HRTI PRIVATE LIMITEDBulkSell04 Mar 20251020.52769,580NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkSell04 Mar 20251024.35523,967NSE
GRAVITON RESEARCH CAPITAL LLPBulkSell04 Mar 20251029.531,180,400NSE
HRTI PRIVATE LIMITEDBulkPurchase04 Mar 20251019.30814,594NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkPurchase04 Mar 20251023.88523,967NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase04 Mar 20251029.061,180,400NSE
GRAVITON RESEARCH CAPITAL LLPBulkSell27 Feb 2025977.10598,243NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase27 Feb 2025975.72598,243NSE
All deals
All insider trades

Vijaya Diagnostic Centre Corporate Actions

Vijaya Diagnostic Centre Dividend history and yield

Vijaya Diagnostic Centre dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Vijaya Diagnostic Centre dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
116 Sep 2026
2FINAL16 Sep 2026Equity Share
229 Aug 2025
2FINAL29 Aug 2025Equity Share
330 Aug 2024
1FINAL30 Aug 2024Equity Share
413 Sep 2023
1FINAL13 Sep 2023Equity Share
520 Sep 2022
1FINAL21 Sep 2022Equity Share

Vijaya Diagnostic Centre Board Meetings

Vijaya Diagnostic Centre past and upcoming board meetings.

#Ex-Date
PurposeNotes
103 Nov 2026
Quarterly Results-
206 Aug 2026
Quarterly Results-
307 May 2026
Audited Results & Final Dividend-
413 Feb 2026
Quarterly Results-
504 Nov 2025
Quarterly Results-
All Corporate Actions

Vijaya Diagnostic Centre Research Reports

Vijaya Diagnostic Centre research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
111 Oct 2026Axis Direct17301452.1Buy19.14%-0.44%pdf
208 Aug 2026ICICI Securities Limited
Reco
Target
16001351.1Buy18.42%7%pdf
323 Jun 2026Emkay
Target
14001312.6Buy6.66%10.14%pdf
404 Nov 2025ICICI Securities Limited
Reco
Target
9501025.25Sell-7.34%41.01%pdf
512 May 2025Emkay1150970.1Buy18.54%49.03%pdf
All Reports of Vijaya

Vijaya Diagnostic Centre Corporate Filings

Vijaya Diagnostic Centre BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
28 Oct 2026
Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Initmation of Earning Conference Call
PDF
28 Oct 2026
Vijaya Diagnostic Centre Ltd - 543350 - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the unaudited Financial Results for the Quarter and half year ended September 30, 2026.
PDF
06 Oct 2026
Vijaya Diagnostic Centre Ltd - 543350 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ending September 30, 2026.
PDF
28 Sep 2026
Vijaya Diagnostic Centre Ltd - 543350 - Closure of Trading Window
The Trading Window for dealing in securities of the company for all the Designated Persons (DP) and their immediate relatives shall remain closed w.e.f. Thursday, October 1, 2026 till the end of 48 hours after the announcement of the un-audited financial results of the company for the quarter ending September 30, 2026 to the public.
PDF
26 Sep 2026
Vijaya Diagnostic Centre Ltd - 543350 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results along with the Scrutiniser Report of the 24th AGM Held on 24th September 2026.
PDF
VIEW ALL

Vijaya Diagnostic Centre DocumentsAsk MarketMind AI

Vijaya Diagnostic Centre Earnings Call

Vijaya Diagnostic Centre earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Aug 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
13 May 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
08 May 2026Vijaya Diagnostic Centre Results Earnings Call for Q4FY26 & Full YearAudioVideo
19 Feb 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
07 Nov 2025Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAi summaryLink
view all

Vijaya Diagnostic Centre Annual Reports

Vijaya Diagnostic Centre financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link
2023Annual Report Mar-2023Link
2022Annual Report Mar-2022Link

Vijaya Diagnostic Centre Credit Ratings

Vijaya Diagnostic Centre credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
24 Jun 2026crisil ratingsVijaya Diagnostic Centre LimitedVijaya Diagnostic Centre Limited:Issuer not cooperating, based on best-available information; Ratings revised to \u2018Crisil B/Stable/Crisil A4 Issuer not cooperating\u2019Link
29 Apr 2025crisil ratingsVijaya Diagnostic Centre LimitedVijaya Diagnostic Centre Limited:Issuer not cooperating, based on best-available information; Ratings continues to be \u2018Crisil B+/Stable/Crisil A4 Issuer not cooperating'Link
07 Oct 2024icra ratingsVijaya Diagnostic Centre LimitedRatings Reaffirmed and WithdrawnLink
28 Feb 2024crisil ratingsVijaya Diagnostic Centre LimitedVijaya Diagnostic Centre Limited:Issuer not cooperating, based on best-available information; Ratings continues to be \u2018CRISIL B+/Stable/CRISIL A4 Issuer not cooperating'Link
28 Dec 2023icra ratingsVijaya Diagnostic Centre LimitedUpdate on Material EventLink

Vijaya Diagnostic Centre Investor Presentations

Vijaya Diagnostic Centre investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
11 Sep 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
06 Aug 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
07 May 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
13 Feb 2026Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
04 Nov 2025Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Vijaya Diagnostic Centre - Company Profile

Vijaya Diagnostic Centre Management Structure

Vijaya Diagnostic Centre management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Sura Suprita ReddyExecutive Director,Managing Director,Chief Executive Officer-Mar 26
Mr. Narasimha RajuChief Financial Officer-Mar 26
NAGA VASUDHA TADEPALLICompany Secretary,Compliance Officer-Mar 26
Sivaramaraju VegesnaChief Operating Officer-Mar 26
Dr. Kiran BDirector(Laboratory)-Mar 26
Dr. V VijayanandDirector(Radiology)-Mar 26

Vijaya Diagnostic Centre Board of Directors

Vijaya Diagnostic Centre Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Sura Suprita ReddyManaging Director & CEO275Mar 26
Sura Surendranath ReddyChairman & Exec. Director200Mar 26
Sunil Chandra KondapallyE D & Wholetime Director100Mar 26
C S N MurthyIndependent Non Exe. Director12Mar 26
S RaviIndependent Non Exe. Director1.53Mar 26
SASIKALA PARUCHURI KOLAIndependent Non Exe. Director1.53Mar 26
Sura Geeta ReddyNon-Exec & Non-Independent Dir-Mar 26
DIPINDER SINGH SEKHONIndependent Non Exe. Director-Mar 26
Website: www.vijayadiagnostic.com

About the company - Business Profile

Vijaya Diagnostic Centre Limited, established in 1981, is a leading integrated diagnostic service provider in India, with a dominant presence in Southern India, particularly Telangana and Andhra Pradesh. The company operates a comprehensive business model offering over 2,000 pathology and 700 radiology tests under one roof. It follows a hub-and-spoke model to provide high-quality diagnostic services, ranging from basic blood tests to advanced imaging like PET-CT and 3T MRI. As of December 2025, the company has expanded its network to 162 diagnostic centres across 27 cities and towns, serving a significant B2C customer base.

Key Points

  • Key Facts: Founded in 1981 by Dr. S. Surendranath Reddy and headquartered in Hyderabad. The company is listed on both the National Stock Exchange (NSE: VIJAYA) and BSE Limited (BSE: 543350).
  • Operations and Resources: As of December 31, 2025, the company operates 162 diagnostic centres and 17 NABL-accredited laboratories. Its infrastructure includes 30 CT machines and advanced equipment like PET-CT and "BioMatrix 3T" MRI.
  • Ownership and History: Founded as a private entity, the company transitioned to a public listed company in 2021. It remains promoter-led, with Ms. Suprita Reddy serving as the Managing Director & CEO.
  • Business Model and Expertise: The company follows a B2C-focused model (contributing ~92% of revenue) with a strong emphasis on "integrated" diagnostics (pathology and radiology at the same location). It excels in providing high-end radiology services alongside routine pathology.
  • Revenue Breakdown (FY 2024-25):
    • Total Revenue: ₹6,814 million, representing a growth of 24.4% YoY.
    • Segment Mix (Q3 FY26): Pathology accounts for 62.9% and Radiology for 37.1% of revenue.
    • Geographical Concentration: Hyderabad remains the primary market contributing ~68-69% of revenue. Other regions include Rest of Andhra Pradesh & Telangana (RoAPT) at 19%, Pune at 6%, and Kolkata at 3%.
    • Wellness Share: Preventive health check-ups (Wellness) contributed 14.5% to the total revenue in 9M FY26.
  • Technology and Innovation:
    • Transitioned to Augmento, an AI-based radiology software in 2024.
    • First independent diagnostic centre in South India to offer PET-CT from Wipro GE Healthcare.
    • Implementation of advanced diagnostic tools like Droplet Digital PCR (ddPCR) and 3D Mammography.
  • Clients and Partnerships: Engages with over 450 corporate clients for preventive health programmes. Strategic acquisition of PH Diagnostics in Pune (2023) and merger of Medinova Diagnostic Services Limited (effective April 2024) have bolstered its presence in Western and Eastern India.
  • Employee Base: Employs an in-house team of over 300 experienced radiologists and pathologists.
  • Strategic Initiatives and Outlook:
    • Geographic Expansion: Recently entered the Bengaluru market with two hubs (Yelahanka and HSR Layout) in October 2025.
    • Future Growth: Planned expansion includes 1 new hub and 10 spokes in Bengaluru and further expansion in West Bengal and RoAPT during H2 FY26 and H1 FY27.
    • Acquisitions: Successful integration of PH Diagnostics and Medinova to drive inorganic growth.

References

  1. Annual Report Mar 2025
  2. Investor Presentation Feb 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024

Vijaya Diagnostic Centre FAQ

Vijaya Diagnostic Centre today is trading in the red, down by 1.26% at ₹1,445.7.
Vijaya Diagnostic Centre is currently trading down 1.26% on an intraday basis. In the past week the stock rose 4.05%. Stock has been up 7.53% in the past quarter and rose 46.23% in the past year. You can view this in the share price history/seasonality section.
Vijaya Diagnostic Centre is listed on NSE with the ticker VIJAYA and on BSE as 543350. It's currently trading on NSE at a share price of ₹1,445.7 and on BSE with a share price of ₹1,435.
The market cap of Vijaya Diagnostic Centre is ₹14,890.38 Cr. as of Oct 30, 2026.
Vijaya Diagnostic Centre announced a FINAL dividend of 200% which equals ₹2 in Sep 16, 2026.The last three ex-dates for Vijaya Diagnostic Centre were Aug 29, 2025, Aug 30, 2024 and Sep 13, 2023. To view the full dividend history of Vijaya Diagnostic Centre click here.
Vijaya Diagnostic Centre has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Vijaya Diagnostic Centre reported ₹239.51 Cr. in revenue, ₹53.1 Cr. in net profit, and ₹107.07 Cr. in EBITD as of Aug 06, 2026 for Q1 FY26-27.
According to the predictions of 10 analysts, the share price prediction for Vijaya Diagnostic Centre is ₹1,554.8 with an upside of 8%.
The PE ratio of Vijaya Diagnostic Centre is 79.42 as of Oct 30, 2026.
The PB ratio of Vijaya Diagnostic Centre is 14.74 as of Oct 30, 2026.
You can view the latest analyst reports on the Vijaya Diagnostic Centre reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×